Objectives Evaluate the risks and benefits of upadacitinib 15 mg vs adalimumab in rheumatoid arthritis (RA) patients with an inadequate response to methotrexate based on cardiovascular (CV) risk.
Objective To assess whether joint involvement during palindromic rheumatism (PR) flares predicts future arthritis location in patients progressing to persistent inflammatory arthritis (PIA) and to ...
Background Renal involvement in ankylosing spondylitis (AS) is recognised but understudied, with heterogeneous reports ranging from urinalysis abnormalities to end-stage disease and malignancy. Robust ...
Objective To examine associations between participants’ perinatal factors, including harmonised birth weight and length, prematurity, exposure to maternal smoking during pregnancy and breastfeeding ...
1 Department of Internal Medicine and Infectious Diseases, Versailles Hospital, Le Chesnay, France 2 Department of Cardiology, Versailles Hospital, Le Chesnay, France A 17-year-old Caucasian male ...
Objectives To determine the prevalence of depressive and anxiety symptoms among young people 7 years and 9 years after ...
Introduction Antiphospholipid syndrome (APS) is an autoimmune disease characterised by obstetric morbidity and recurrent ...
Background The proportion of patients with giant cell arteritis (GCA)-related large vessel vasculitis (LVV) treated with tocilizumab (TCZ) who achieve a complete metabolic response on repeated 18 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results